Suppliers / Curia Missouri

Curia Missouri

United States Updated 9 July 2026

The public registers hold a second record for Curia Missouri. The fuller profile, with 116 active US DMFs and 8 valid CEPs, is at Curia. Figures on this page cover only this record.

Curia Missouri is an API manufacturer based in United States. It holds 7 active US drug master files across a filed portfolio of 7 molecules. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 2 December 2025 as NAI.

7
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
6 of 6 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 2 December 2025 NAI US FDA
  • 2 August 2019 NAI US FDA
  • 9 February 2017 NAI US FDA
  • 8 August 2014 NAI US FDA
  • 6 January 2012 NAI US FDA
  • 22 April 2010 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Springfield, United States 1941037

What they file, and where

Molecule Regulators Docs
Choline Fenofibrate US FDA 1
Dexmethylphenidate US FDA 1
Lacosamide US FDA 1
Methylphenidate US FDA 1
Regadenoson US FDA 1
Sodium Oxybate US FDA 1
Tapentadol US FDA 1

Also appears on these molecule pages

Choline Fenofibrate API Dexmethylphenidate API Lacosamide API Methylphenidate API Regadenoson API Sodium Oxybate API Tapentadol API

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA None 1

Questions about Curia Missouri

Does Curia Missouri hold a US DMF or a CEP?
Curia Missouri holds 7 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Curia Missouri FDA-registered?
One site operated by Curia Missouri carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Curia Missouri's last inspection go?
The most recent inspection on record closed on 2 December 2025 as NAI (No Action Indicated: nothing objectionable was found). 6 inspections are on file.
Where does Curia Missouri manufacture?
1 registered site is on record, in United States (Springfield). Every site is listed on this page with the register it came from.
What does Curia Missouri make?
7 molecules are on record against Curia Missouri, including Choline Fenofibrate, Dexmethylphenidate, Lacosamide and Methylphenidate. Each links through to that molecule's full manufacturer list.
Which regulators recognise Curia Missouri's GMP?
Current GMP certificates are on record from US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Curia Missouri comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 2 December 2025.

Comparable suppliers

Alkem Laboratories shares 4 molecules Veranova Lp shares 3 molecules Ampac Fine Chemicals shares 3 molecules Alivus Life Sciences shares 2 molecules Gland Pharma shares 2 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates